col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


15 Results       Page 1

 [1] 
Springer-Verlag: International Journal of Clinical Oncology
  original article Date Title Authors   All Authors
1 [GO] 2025―Jul―23 Impact of prior COVID-19 infection on perioperative outcomes in non-small cell lung cancer patients: a prospective observational cohort study Hanbo Pan, Fan Shen, Ningyuan Zou, Yu Tian, Jiaqi Zhang, Yixing Tao, et al. (+3)
2 [GO] 2025―Jan―16 Analysis of lung cancer incidence, mortality trends, and smoking rates in Japan:1975-2022 with insights on the impact of COVID-19 Hiroki Yamamoto, Masayuki Shirasawa, Katsuhiko Naoki
3 [GO] 2024―Feb―21 Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study Yuki Katsuya, Tatsuya Yoshida, Atsuo Takashima, Kan Yonemori, Akihiro Ohba, Shu Yazaki, et al. (+7)
4 [GO] 2023―Dec―06 Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan Hiroaki Komatsu, Yuji Ikeda, Kei Kawana, Satoru Nagase, Kiyoshi Yoshino, Wataru Yamagami, et al. (+5)
5 [GO] 2023―Mar―01 Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients Apar Kishor Ganti, Nathanael R. Fillmore, John Bihn, Jennifer La, Mary T. Brophy, Nhan V. Do, Michael Kelley
6 [GO] 2023―Feb―23 Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies Teresita Caruso, Francesca Salani, Silvia Catanese, Federico Pratesi, Chiara Mercinelli, Giuseppe Motta, et al. (+5)
7 [GO] 2023―Jan―23 Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies Caruso Teresita, Salani Francesca, Catanese Silvia, Pratesi Federico, Mercinelli Chiara, Motta Giuseppe, et al. (+5)
8 [GO] 2022―Mar―28 Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan Shohei Fujita, Shinichi Sakuramoto, Yutaka Miyawaki, Yosuke Morimoto, Gen Ebara, Keiji Nishibeppu, et al. (+6)
9 [GO] 2021―Dec―04 Correction to: COVID-19 infection in pediatric patients treated for cancer Lital Oz-Alcalay, Sarah Elitzur, Nofar Amitai, Helen Toledano, Shlomit Barzilai-Birenboim, Gali Avrahami, et al. (+6)
10 [GO] 2021―Nov―06 COVID-19 infection in pediatric patients treated for cancer Lital Oz-Alcalay, Sarah Elitzur, Nofar Amitai, Helen Toledano, Shlomit Barzilai-Birenboim, Gali Avrahami, et al. (+6)
11 [GO] 2021―Jun―18 Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic Michal Dvori, Sarah Elitzur, Assaf Barg, Shlomit Barzilai-Birenboim, Gil Gilad, Shirah Amar, et al. (+8)
12 [GO] 2021―Jan―24 The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study Gulcin Sahingoz Erdal, Ozlem Polat, Gokmen Umut Erdem, Ramazan Korkusuz, Fehmi Hindilerden, Mesut Yilmaz, et al. (+3)
13 [GO] 2020―Nov―23 Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan Shohei Nakamura, Yusuke Kanemasa, Yuya Atsuta, Sho Fujiwara, Masaru Tanaka, Kazuaki Fukushima, et al. (+5)
14 [GO] 2020―Oct―21 Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research Daisuke Takahari, Eiji Shinozaki, Takeru Wakatsuki, Akira Ooki, Masato Ozaka, Takeshi Suzuki, et al. (+8)
15 [GO] 2020―Jul―11 Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic Mozaffar Aznab
 [1] 

15 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec